Amundi Asset Management US’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $37.7M | Buy |
456,699
+22,613
| +5% | +$1.86M | 0.03% | 497 |
|
|
2020
Q4 | $39.5M | Buy |
434,086
+301,687
| +228% | +$27.4M | 0.03% | 457 |
|
|
2020
Q3 | $5.29M | Buy |
132,399
+124,799
| +1,642% | +$4.99M | 0.01% | 877 |
|
|
2020
Q2 | $261K | Sell |
7,600
-100
| -1% | -$3.43K | ﹤0.01% | 1327 |
|
|
2020
Q1 | $171K | Buy |
+7,700
| New | +$171K | ﹤0.01% | 1346 |
|
|
2019
Q3 | – | Sell |
-34,439
| Closed | -$699K | – | 1621 |
|
|
2019
Q2 | $699K | Sell |
34,439
-8,504
| -20% | -$173K | ﹤0.01% | 1293 |
|
|
2019
Q1 | $755K | Sell |
42,943
-7,290
| -15% | -$128K | ﹤0.01% | 1236 |
|
|
2018
Q4 | $645 | Sell |
50,233
-1,666
| -3% | -$21 | ﹤0.01% | 1214 |
|
|
2018
Q3 | $845K | Buy |
+51,899
| New | +$845K | ﹤0.01% | 1253 |
|